GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) » Definitions » 5-Year Yield-on-Cost %

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) 5-Year Yield-on-Cost % : 17.97 (As of May. 26, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Pharmedic Pharmaceutical Medicinal Joint Stock Company 5-Year Yield-on-Cost %?

Pharmedic Pharmaceutical Medicinal Joint Stock Company's yield on cost for the quarter that ended in . 20 was 17.97.


The historical rank and industry rank for Pharmedic Pharmaceutical Medicinal Joint Stock Company's 5-Year Yield-on-Cost % or its related term are showing as below:

HSTC:PMC' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 17.97



HSTC:PMC's 5-Year Yield-on-Cost % is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.125 vs HSTC:PMC: 17.97

Competitive Comparison of Pharmedic Pharmaceutical Medicinal Joint Stock Company's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmedic Pharmaceutical Medicinal Joint Stock Company's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmedic Pharmaceutical Medicinal Joint Stock Company's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmedic Pharmaceutical Medicinal Joint Stock Company's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Pharmedic Pharmaceutical Medicinal Joint Stock Company's 5-Year Yield-on-Cost % falls into.



Pharmedic Pharmaceutical Medicinal Joint Stock Company 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Pharmedic Pharmaceutical Medicinal Joint Stock Company is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Pharmedic Pharmaceutical Medicinal Joint Stock Company  (HSTC:PMC) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Pharmedic Pharmaceutical Medicinal Joint Stock Company 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Pharmedic Pharmaceutical Medicinal Joint Stock Company's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Business Description

Traded in Other Exchanges
N/A
Address
367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM
Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, pharmaceuticals, cosmetics, medical supplies, and other products in the health sector.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Headlines

From GuruFocus

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk 06-25-2012

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor 11-16-2009

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor 08-13-2010